List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Human Papillomavirus Protein E7 (E7) - Overview
Human Papillomavirus Protein E7 (E7) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Human Papillomavirus Protein E7 (E7) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Human Papillomavirus Protein E7 (E7) - Companies Involved in Therapeutics Development
Abion Inc
Advaxis Inc
AstraZeneca Plc
Bioleaders Corp
BioNTech SE
Cellid Co Ltd
Cue Biopharma Inc
Etubics Corp
Genexine Inc
Hookipa Pharma Inc
iBio Inc
Immunomic Therapeutics Inc
IMV Inc
Innovene
Inovio Pharmaceuticals Inc
Oxford Vacmedix UK Ltd
Papivax LLC
Selecta Biosciences Inc
Touchlight Genetics Ltd
Transgene SA
UbiVac LLC
ViciniVax BV
Vir Biotechnology Inc
VLP The Vaccines Company SL
Human Papillomavirus Protein E7 (E7) - Drug Profiles
(bizalimogene ralaplasmid + mavilimogene ralaplasmid) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ABI-231 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ABN-301 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Antibodies to Inhibit E7 for HPV Associated Cancer - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Aptamer to Target HPV E7 Protein for Cervical Cancer - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Human Papillomavirus Protein E7 (E7) - Dormant Products
Human Papillomavirus Protein E7 (E7) - Discontinued Products
Human Papillomavirus Protein E7 (E7) - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development by Stage of Development, H2 2019
Number of Products under Development by Therapy Areas, H2 2019
Number of Products under Development by Indication, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Companies, H2 2019 (Contd..1)
Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Products under Development by Companies, H2 2019 (Contd..2), H2 2019
Products under Development by Companies, H2 2019 (Contd..3), H2 2019
Products under Development by Companies, H2 2019 (Contd..4), H2 2019
Number of Products under Investigation by Universities/Institutes, H2 2019
Products under Investigation by Universities/Institutes, H2 2019
Products under Investigation by Universities/Institutes, H2 2019 (Contd..1), H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Pipeline by Abion Inc, H2 2019
Pipeline by Advaxis Inc, H2 2019
Pipeline by AstraZeneca Plc, H2 2019
Pipeline by Bioleaders Corp, H2 2019
Pipeline by BioNTech SE, H2 2019
Pipeline by Cellid Co Ltd, H2 2019
Pipeline by Cue Biopharma Inc, H2 2019
Pipeline by Etubics Corp, H2 2019
Pipeline by Genexine Inc, H2 2019
Pipeline by Hookipa Pharma Inc, H2 2019
Pipeline by iBio Inc, H2 2019
Pipeline by Immunomic Therapeutics Inc, H2 2019
Pipeline by IMV Inc, H2 2019
Pipeline by Innovene, H2 2019
Pipeline by Inovio Pharmaceuticals Inc, H2 2019
Pipeline by Oxford Vacmedix UK Ltd, H2 2019
Pipeline by Papivax LLC, H2 2019
Pipeline by Selecta Biosciences Inc, H2 2019
Pipeline by Touchlight Genetics Ltd, H2 2019
Pipeline by Transgene SA, H2 2019
Pipeline by UbiVac LLC, H2 2019
Pipeline by ViciniVax BV, H2 2019
Pipeline by Vir Biotechnology Inc, H2 2019
Pipeline by VLP The Vaccines Company SL, H2 2019
Dormant Products, H2 2019
Dormant Products, H2 2019 (Contd..1), H2 2019
Dormant Products, H2 2019 (Contd..2), H2 2019
Discontinued Products, H2 2019

List of Figures
Number of Products under Development by Stage of Development, H2 2019
Number of Products under Development by Therapy Areas, H2 2019
Number of Products under Development by Top 10 Indications, H2 2019
Number of Products by Mechanism of Actions, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Top 10 Routes of Administration, H2 2019
Number of Products by Stage and Top 10 Routes of Administration, H2 2019
Number of Products by Top 10 Molecule Types, H2 2019
Number of Products by Stage and Top 10 Molecule Types, H2 2019

Companies Mentioned
• Abion Inc
• Advaxis Inc
• AstraZeneca Plc
• Bioleaders Corp
• BioNTech SE
• Cellid Co Ltd
• Cue Biopharma Inc
• Etubics Corp
• Genexine Inc
• Hookipa Pharma Inc
• iBio Inc
• Immunomic Therapeutics Inc
• IMV Inc
• Innovene
• Inovio Pharmaceuticals Inc
• Oxford Vacmedix UK Ltd
• Papivax LLC
• Selecta Biosciences Inc
• Touchlight Genetics Ltd
• Transgene SA
• UbiVac LLC
• ViciniVax BV
• Vir Biotechnology Inc
• VLP The Vaccines Company SL